Skip to main content
. 2014 Jan 21;28(1):19–25. doi: 10.3341/kjo.2014.28.1.19

Fig. 1.

Fig. 1

Visual acuity as measured by a Snellen chart at each follow-up interval. The three groups showed no statistically significant difference in visual acuity in most of the follow-up interval except for the 12-month follow-up, at which time the intravitreal triamcinolone injection (IVTA) group showed a statistically significant decrease in visual acuity (graphed on the logarithm of the minimum angle of resolution [logMAR] scale). IVB = intravitreal bevacizumab injection.